Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Therapeutic Drug Monitoring|May 22, 2002
New limited sampling strategy for determining 5-fluorouracil area under the concentration-time curve after rapid intravenous bolusMilena Gusella, Eros Ferrazzi, Mariano Ferrari, et al.
British Journal of Clinical Pharmacology|September 5, 2002
Relationships between body composition parameters and fluorouracil pharmacokineticsMilena Gusella, Sivia Toso, Eros Ferrazzi, et al.
Therapeutic Drug Monitoring|November 25, 2005
Effect of hemodialysis on the metabolic clearance of 5-Fluorouracil in a patient with end-stage renal failureMilena Gusella, Mirca Rebeschini, Giuseppe Cartei, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|June 5, 2003
Bioimpedance vector pattern in cancer patients without disease versus locally advanced or disseminated diseaseSilvia Toso, Antonio Piccoli, Milena Gusella, et al.
Genes, Chromosomes & Cancer|September 24, 2004
Cryptic insertion producing two NUP98/NSD1 chimeric transcripts in adult refractory anemia with an excess of blastsRoberta La Starza, Paolo Gorello, Roberto Rosati, et al.
International Journal of Oncology|November 18, 2004
Adrenomedullin (AM) and AM receptor type 2 expression is up-regulated in prostate carcinomas (PC), and AM stimulates in vitro growth of a PC-derived cell line by enhancing proliferation and decreasing apoptosis ratesGiuseppina Mazzocchi, Ludwik K Malendowicz, Agnieszka Ziolkowska, et al.
Cancer|September 5, 2002
Phase II trial of interferon-alpha-2a plus psolaren with ultraviolet light A in patients with cutaneous T-cell lymphomaVanna Chiarion-Sileni, Antonio Bononi, Cleto Veller Fornasa, et al.
Journal of Hematotherapy & Stem Cell Research|September 11, 2003
CXCR-4 expression on bone marrow CD34+ cells prior to mobilization can predict mobilization adequacy in patients with hematologic malignanciesMelissa Dabusti, Francesco Lanza, Diana Campioni, et al.
Cancer Research|November 19, 2004
Frequent aberrant methylation of the CDH4 gene promoter in human colorectal and gastric cancerElena Miotto, Silvia Sabbioni, Angelo Veronese, et al.
Cancer Research|July 10, 2007
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinomaLaura Gramantieri, Manuela Ferracin, Francesca Fornari, et al.
Pageof 2